{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:02:31Z","timestamp":1790474551424,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006662","name":"National Institute on Handicapped Research","doi-asserted-by":"publisher","award":["2021-2024"],"award-info":[{"award-number":["2021-2024"]}],"id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_PC_20030"],"award-info":[{"award-number":["MC_PC_20030"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V015737\/1"],"award-info":[{"award-number":["MR\/V015737\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_PC_20059"],"award-info":[{"award-number":["MC_PC_20059"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["NIHR200929"],"award-info":[{"award-number":["NIHR200929"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["NIHR207408"],"award-info":[{"award-number":["NIHR207408"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MR\/W021420\/1"],"award-info":[{"award-number":["MR\/W021420\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012360","name":"Heart of England NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["222097\/Z\/20\/Z [2020\\u20132024"],"award-info":[{"award-number":["222097\/Z\/20\/Z [2020\\u20132024"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["COV-LT-0009"],"award-info":[{"award-number":["COV-LT-0009"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["MC_PC_20051"],"award-info":[{"award-number":["MC_PC_20051"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ebiom.2026.106327","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:15:18Z","timestamp":1782479718000},"page":"106327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Factors associated with severe COVID-19 in immunocompromised subgroups in England from 2020 to 2024: an OpenSAFELY cohort study"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5847-109X","authenticated-orcid":false,"given":"Edward P.K.","family":"Parker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hartney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Nab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayatri","family":"Amirthalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor V.H.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian J.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2551-410X","authenticated-orcid":false,"given":"Kathryn E.","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9021-0487","authenticated-orcid":false,"given":"Anne","family":"Suffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0891-714X","authenticated-orcid":false,"given":"Meredith","family":"Leston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"MacKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Hulme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8848-9493","authenticated-orcid":false,"given":"Laurie A.","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2026.106327_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106432","article-title":"Immunocompromised individuals remain at risk of COVID-19: 2023 results from the observational INFORM study","volume":"90","author":"Quint","year":"2025","journal-title":"J Infect"},{"key":"10.1016\/j.ebiom.2026.106327_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.01.009","article-title":"Disparities in COVID-19 mortality amongst the immunosuppressed: a systematic review and meta-analysis for enhanced disease surveillance","volume":"88","author":"Leston","year":"2024","journal-title":"J Infect"},{"key":"10.1016\/j.ebiom.2026.106327_bib4","article-title":"Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study","volume":"35","author":"Evans","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.ebiom.2026.106327_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071249","article-title":"Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records","volume":"378","author":"Horne","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.ebiom.2026.106327_bib6","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/s41591-023-02414-4","article-title":"SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease","volume":"29","author":"Barnes","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2026.106327_bib7","doi-asserted-by":"crossref","first-page":"e326","DOI":"10.1016\/S2214-109X(21)00593-3","article-title":"Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review","volume":"10","author":"Parker","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ebiom.2026.106327_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jinf.2023.08.005","article-title":"COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: english primary care network cohort study","volume":"87","author":"Whitaker","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.ebiom.2026.106327_bib9","article-title":"Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study","volume":"379","author":"Ferdinands","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.ebiom.2026.106327_bib10","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0140-6736(22)00104-0","article-title":"Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients","volume":"399","author":"Carr","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2026.106327_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106261","article-title":"Comparative effectiveness of bivalent BA.4\u20135 or BA.1 mRNA booster vaccines among immunocompromised individuals across three Nordic countries: a nationwide cohort study","volume":"89","author":"Gram","year":"2024","journal-title":"J Infect"},{"key":"10.1016\/j.ebiom.2026.106327_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/pds.5815","article-title":"OpenSAFELY: a platform for analysing electronic health records designed for reproducible research","volume":"33","author":"Nab","year":"2024","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ebiom.2026.106327_bib13","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1016\/S2468-2667(23)00079-8","article-title":"Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform","volume":"8","author":"Nab","year":"2023","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.ebiom.2026.106327_bib14","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2026.106327_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102077","article-title":"Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platform","volume":"61","author":"Costello","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.ebiom.2026.106327_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-072808","article-title":"Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPP","volume":"380","author":"Hulme","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.ebiom.2026.106327_bib17","article-title":"Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study","volume":"30","author":"Parker","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.ebiom.2026.106327_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.12688\/wellcomeopenres.18010.1","article-title":"OpenSAFELY: representativeness of electronic health record platform OpenSAFELY-TPP data compared to the population of England","volume":"7","author":"Andrews","year":"2022","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.ebiom.2026.106327_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1491565","article-title":"Developing a digital phenotype to subdivide adult immunosuppressed COVID-19 outcomes within the English Primary Care Sentinel Network","volume":"15","author":"Leston","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2026.106327_bib21","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.2020.1267","article-title":"Why test for proportional hazards?","volume":"323","author":"Stensrud","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2026.106327_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies conducted using Observational Routinely-collected health Data (RECORD) Statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.ebiom.2026.106327_bib23","series-title":"NIHR HPRU in immunisation: public engagement in vaccine research","year":"2024"},{"key":"10.1016\/j.ebiom.2026.106327_bib26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/aje\/kwad179","article-title":"Challenges in estimating the effectiveness of 2 doses of COVID-19 vaccine beyond 6 months in England","volume":"193","author":"Horne","year":"2024","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ebiom.2026.106327_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106177","article-title":"Effectiveness of autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control study","volume":"89","author":"Kirsebom","year":"2024","journal-title":"J Infect"},{"key":"10.1016\/j.ebiom.2026.106327_bib28","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/S1473-3099(23)00744-2","article-title":"Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure","volume":"24","author":"Yang","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2026.106327_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068632","article-title":"Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis","volume":"376","author":"Lee","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.ebiom.2026.106327_bib30","article-title":"Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study","volume":"371","author":"Clift","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ebiom.2026.106327_bib31","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(22)01656-7","article-title":"Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales","volume":"400","author":"Agrawal","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2026.106327_bib32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra2206573","article-title":"Covid-19 vaccines \u2014 immunity, variants, boosters","volume":"387","author":"Barouch","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2026.106327_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.839433","article-title":"Mind the \u201cVaccine Fatigue.\u201d","volume":"13","author":"Su","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2026.106327_bib34","article-title":"Safety of medicines delivered by homecare companies","volume":"361","author":"Matthews","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.ebiom.2026.106327_bib35","doi-asserted-by":"crossref","first-page":"360","DOI":"10.12688\/wellcomeopenres.17360.1","article-title":"A comprehensive high cost drugs dataset from the NHS in England - an OpenSAFELY-TPP Short Data Report","volume":"6","author":"Rowan","year":"2021","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.ebiom.2026.106327_bib36","doi-asserted-by":"crossref","first-page":"e490","DOI":"10.1016\/S2665-9913(22)00098-4","article-title":"Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform","volume":"4","author":"MacKenna","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ebiom.2026.106327_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2023-000807","article-title":"Identification of patients undergoing chronic kidney replacement therapy in primary and secondary care data: validation study based on OpenSAFELY and UK Renal Registry","volume":"3","author":"Santhakumaran","year":"2024","journal-title":"BMJ Med"},{"key":"10.1016\/j.ebiom.2026.106327_bib38","article-title":"Long-term kidney outcomes after COVID-19: a matched cohort study using the OpenSAFELY platform","volume":"55","author":"Mahalingasivam","year":"2025","journal-title":"Lancet Reg Health Eur"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:13:57Z","timestamp":1783498437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426002094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":34,"alternative-id":["S2352396426002094"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106327","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with severe COVID-19 in immunocompromised subgroups in England from 2020 to 2024: an OpenSAFELY cohort study","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106327"}}